Abstract
As an emerging disease, effective drug interventions are not expected to be available for several months and medical resources to treat cases will be limited. Therefore, non-pharmaceutical interventions (NPI) are an important part of the public health response to the epidemic. But different countries have different strategies, resulting in different situations of intervention implementation and different epidemic development. These interventions are implemented differently in different countries, and several factors limit their development. In this article, these will be summarized from policy, economy, society, and legal system aspects, hoping to provide advice for countries that do not do well in the intervention strategies of COVID-19 by analyzing the reasons.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
